The Online Investor

Slideshow IPOs

By The Online Investor Staff, updated Sun., Apr. 11, 9:48 PM

Slide #1. VectivBio Holding AG Initial Public Offering

Company: VectivBio Holding AG
Proposed Symbol: VECT
Shares Offered: 7,500,000
Price Per Share: $17.00
Over-Allotment: 1,125,000
Description: VectivBio Holding AG, ("Vectiv" or "VectivBio") (Nasdaq: VECT), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need, today announced the pricing of its initial public offering of 7,500,000 ordinary shares at a public offering price of $17.00 per share. The gross proceeds to Vectiv, before deducting underwriting discounts and commissions and offering expenses, are expected to be $127.5 million. All of the ordinary shares are being offered by Vectiv. In addition, Vectiv has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 ordinary shares at the initial public offering price, less the underwriting discounts and commissions.

IPOs: VectivBio Holding AG

List of IPOs in this Slideshow: Company Ticker IPO Date Zhihu Inc. ZH two MKFG Achilles Therapeutics plc ACHL Nocturne Acquisition Corporation MBTCU Frontier Group Holdings, Inc. ULCC Nocturne Acquisition Corporation MBTCU Smart Share Global Limited EM Karooooo Ltd. KARO Ace Global Business Acquisition Limited ACBAU UTime Limited UTME Panacea Acquisition Corp. II PANA Model Performance Acquisition Corp. MPACU Global SPAC Partners Co. GLSPU Reneo Pharmaceuticals, Inc. RPHM VectivBio Holding AG VECT

IPOs Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.